Physician
Healthmed Medical Group, INC.
Healthmed Medical Group, INC. was paid $23K by Medicaid between Jan 2018 and Jun 2018, across 31 billing codes. Its largest line is 76942, — 29% of everything it billed.
33Billing provider infoHEALTHMED MEDICAL GROUP, INC.
CLAREMONT, CA 91711
CLAREMONT, CA 91711
33aNPI1366550378assigned 08/29/2006
33bProvider typeFamily Medicine Physician
28Total paid$23K
24GClaims6,023
24DCodes billed31
24AFirst – last monthJan 2018 – Jun 2018
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#1,070 of 2,511
Median peer was paid$13K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,023 | $23K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 76942 | 29% | 390 | 182 | $7K | |
| 20611 | 15% | 301 | 153 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14% | 1,071 | 492 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 435 | 347 | $3K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 7.0% | 148 | 73 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6.5% | 28 | 28 | $2K |
| 94060 | 3.3% | 97 | 49 | $766.64 | |
| 20553 | 2.6% | 382 | 178 | $605.16 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 458 | 286 | $519.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.5% | 428 | 202 | $345.60 |
| 93000 | 1.5% | 38 | 37 | $345.34 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.3% | 348 | 158 | $311.43 |
19 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 297 | $267.13 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 338 | $165.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 98 | $163.32 |
| 93880 | <1% | 12 | $129.66 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 94 | $124.22 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 17 | $89.24 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 151 | $72.94 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 68 | $66.88 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 299 | $31.66 |
| 80061 | Lipid panel | <1% | 43 | $17.19 |
| 82948 | <1% | 273 | $16.79 | |
| 80053 | Comprehensive metabolic panel | <1% | 44 | $9.74 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 27 | $7.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 29 | $2.80 |
| 84439 | <1% | 14 | $0.01 | |
| 82150 | 0% | 30 | $0.00 | |
| 84480 | 0% | 14 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 15 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBADIHIAN, BIJAN (DIRECTOR)